Relationship of biofilm strength levels in Candida albicans isolates with the type of clinical specimens

علاقة مستويات قوة الغشاء الحيوي في عزلات المبيضات البيضاء بنوع العينات السريرية

Authors

  • Kawther Hafez Jabbar Al-sabti Collage of science
  • Raed Ali Hussain Shabaa Department of Pathological Analyses, Faculty of Science, University of Kufa, Kufa, Iraq.

DOI:

https://doi.org/10.36320/ajb/v16.i2.16560

Keywords:

candida albicans, The virulence factors, biofilm formation, immunocompromised patients.

Abstract

The virulence factors in C. albicans such as biofilm formation, germ tube, adhesion, hydrolytic enzymes, such as lipases, proteases, phospholipases, and hemolysin and catalase enzyme that allow successful colonization and infection of the host under suitable predisposing conditions. A total of 151 clinical specimens were collected from immunocompromised patients suffering from underlying diseases included cancer, diabetes, and thalassemia. All the collected specimens were cultured on yeast selective media. From the total clinical specimens 111 (73.50%) specimens were positive for yeast growth, among them the most predominant species was C. albicans at 64 (57.65%). There was a difference in the prevalence of yeast species isolates according to the patient’s gender, which it was higher in females 76 (68.46%) than in males 35 (31.53%), The virulence factors results showed that all isolates belonging to the species C.albicans form the germ tube when incubated at a temperature of 37°C for 3 hours in 0.5 ml of human serum  while all the isolates of C. albicans showed a positive result to adhesion test after incubation for 1h at 37Cº The test results showed that from 64 C. albicans isolates, there were 16 (25%) strong biofilm producers, 6 (14.28%) were considered as weak biofilm producers. The studies described here form the basis for investigations into the mechanisms of Candida biofilm formation and provide the means to design novel therapies for biofilm-based infections.

Downloads

Download data is not yet available.

References

Colombo, A. L., de Almeida Júnior, J. N., Slavin, M. A., Chen, S. C., & Sorrell, T. C. (2017). Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer. The Lancet. Infectious diseases, 17(11), e344–e356. https://doi.org/10.1016/S1473-3099(17)30304-3

Larcher, R., Platon, L., Amalric, M., Brunot, V., Besnard, N., Benomar, R., Daubin, D., Ceballos, P., Rispail, P., Lachaud, L., Bourgeois, N., & Klouche, K. (2021). Emerging Invasive Fungal Infections in Critically Ill Patients: Incidence, Outcomes and Prognosis Factors, a Case-Control Study. Journal of fungi (Basel, Switzerland), 7(5), 330. https://doi.org/10.3390/jof7050330

Sardi, J. C. O., Scorzoni, L., Bernardi, T., Fusco-Almeida, A. M., & Mendes Giannini, M. J. S. (2013). Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. Journal of medical microbiology, 62(Pt 1), 10–24. https://doi.org/10.1099/jmm.0.045054-0

Russell, C. M., Schaefer, K. G., Dixson, A., Gray, A. L. H., Pyron, R. J., Alves, D. S., Moore, N., Conley, E. A., Schuck, R. J., White, T. A., Do, T. D., King, G. M., & Barrera, F. N. (2022). The Candida albicans virulence factor candidalysin polymerizes in solution to form membrane pores and damage epithelial cells. eLife, 11, e75490. https://doi.org/10.7554/eLife.75490

Richardson, J. P., Brown, R., Kichik, N., Lee, S., Priest, E., Mogavero, S., Maufrais, C., Wickramasinghe, D. N., Tsavou, A., Kotowicz, N. K., Hepworth, O. W., Gallego-Cortés, A., Ponde, N. O., Ho, J., Moyes, D. L., Wilson, D., D'Enfert, C., Hube, B., & Naglik, J. R. (2022). Candidalysins Are a New Family of Cytolytic Fungal Peptide Toxins. mBio, 13(1), e0351021. https://doi.org/10.1128/mbio.03510-21

Morad, H. O. J., Wild, A. M., Wiehr, S., Davies, G., Maurer, A., Pichler, B. J., & Thornton, C. R. (2018). Pre-clinical Imaging of Invasive Candidiasis Using ImmunoPET/MR. Frontiers in microbiology, 9, 1996. https://doi.org/10.3389/fmicb.2018.01996

Chen, H., Zhou, X., Ren, B., & Cheng, L. (2020). The regulation of hyphae growth in Candida albicans. Virulence, 11(1), 337–348. https://doi.org/10.1080/21505594.2020.1748930

Mogavero, S., Sauer, F. M., Brunke, S., Allert, S., Schulz, D., Wisgott, S., Jablonowski, N., Elshafee, O., Krüger, T., Kniemeyer, O., Brakhage, A. A., Naglik, J. R., Dolk, E., & Hube, B. (2021). Candidalysin delivery to the invasion pocket is critical for host epithelial damage induced by Candida albicans. Cellular microbiology, 23(10), e13378. https://doi.org/10.1111/cmi.13378

Costa-de-Oliveira, S., & Rodrigues, A. G. (2020). Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal. Microorganisms, 8(2), 154. https://doi.org/10.3390/microorganisms8020154

Fanning, S., & Mitchell, A. P. (2012). Fungal biofilms. PLoS pathogens, 8(4), e1002585. https://doi.org/10.1371/journal.ppat.1002585

Lohse, M. B., Gulati, M., Johnson, A. D., & Nobile, C. J. (2018). Development and regulation of single- and multi-species Candida albicans biofilms. Nature reviews. Microbiology, 16(1), 19–31. https://doi.org/10.1038/nrmicro.2017.107

Chandra, J., & Mukherjee, P. K. (2015). Candida Biofilms: Development, Architecture, and Resistance. Microbiology spectrum, 3(4), 10.1128/microbiolspec.MB-0020-2015. https://doi.org/10.1128/microbiolspec.MB-0020-2015

Tronchin, G., Pihet, M., Lopes-Bezerra, L. M., & Bouchara, J. P. (2008). Adherence mechanisms in human pathogenic fungi. Medical mycology, 46(8), 749–772. https://doi.org/10.1080/13693780802206435

Tsui, C., Kong, E. F., & Jabra-Rizk, M. A. (2016). Pathogenesis of Candida albicans biofilm. Pathogens and disease, 74(4), ftw018. https://doi.org/10.1093/femspd/ftw018

Kim, D., Shin, W. S., Lee, K. H., Kim, K., Young Park, J., & Koh, C. M. (2002). Rapid differentiation of Candida albicans from other Candida species using its unique germ tube formation at 39 degrees C. Yeast (Chichester, England), 19(11), 957–962. https://doi.org/10.1002/yea.891

Collee, J.G., Miles, R.S. and Watt, B. (1996) Tests for the Identification of Bacteria. In: Collee, J.G., Marmion, B.P., Fraser, A.G. and Simmons, A., Eds., Mackie & McCartney Practical Medical Microbiology, 14th Edition, Churchill Livingstone, New York, 131-151.

de Hoog, G. S.; Guarro, J.; Gené, J.; & Figueras, M. J. (2005). Atlas of clinical fungi. 3rd ed. Centraalbureau voor Schimmelcultures, Utrecht: Netherlands.

Burns T, Breathnach S, Cox N, Griffiths C. (2008). Rook's textbook of dermatology. John Wiley & Sons.volume.7th ed.

Ellis D. Clinical Mycology(1994). The Human Opportunistic Mycoses, Pfizer Inc. (Pub.), 166pp.

Morello JA, Granato PA, Mizer HE (2003). Antimicrobial agent susceptibility testing and resistance. Laboratory manual and workbook, Ed. McGraw: Hill, 95-105.

Kayser FH, Bienz KA, Eckert J, and Zinkernagle RM (2005). Stuttgart: Thieme,. 543-602.

Baradkar, V. P., Mathur, M., & Kumar, S. (2010). Hichrom candida agar for identification of Candida species. Indian journal of pathology & microbiology, 53(1), 93–95. https://doi.org/10.4103/0377-4929.59192

Kathuria, S., Singh, P. K., Sharma, C., Prakash, A., Masih, A., Kumar, A., Meis, J. F., & Chowdhary, A. (2015). Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method. Journal of clinical microbiology, 53(6), 1823–1830. https://doi.org/10.1128/JCM.00367-15

Sudbery P. E. (2001). The germ tubes of Candida albicans hyphae and pseudohyphae show different patterns of septin ring localization. Molecular microbiology, 41(1), 19–31. https://doi.org/10.1046/j.1365-2958.2001.02459.x

Abu-Elteen, K. H. (2005). The influence of dietary carbohydrates on in vitro adherence of four Candida species to human buccal epithelial cells. Microbial Ecology in Health and Disease, 17(3), 156–162. https://doi.org/10.1080/08910600500442917

Henriques, M., Azeredo, J., & Oliveira, R. (2007). The involvement of physico-chemical interactions in the adhesion of Candida albicans and Candida dubliniensis to epithelial cells. Mycoses, 50(5), 391–396. https://doi.org/10.1111/j.1439-0507.2007.01387.x

Saxena, N., Maheshwari, D., Dadhich, D., & Singh, S. (2014). Evaluation of Congo Red Agar for detection of biofilm production by various clinical Candida isolates. Journal of Evolution of Medical and Dental Sciences, 3(59), 13234+. https://link.gale.com/apps/doc/A467679535/HRCA?u=anon~2cd34950&sid=googleScholar&xid=3d30102a

Bergmann O. J. (1991). Alterations in oral microflora and pathogenesis of acute oral infections during remission-induction therapy in patients with acute myeloid leukaemia. Scandinavian journal of infectious diseases, 23(3), 355–366. https://doi.org/10.3109/00365549109024323

Samonis, G., Skordilis, P., Maraki, S., Datseris, G., Toloudis, P., Chatzinikolaou, I., Georgoulias, V., & Bodey, G. P. (1998). Oropharyngeal candidiasis as a marker for esophageal candidiasis in patients with cancer. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 27(2), 283–286. https://doi.org/10.1086/514653

Vila, T., Sultan, A. S., Montelongo-Jauregui, D., & Jabra-Rizk, M. A. (2020). Oral Candidiasis: A Disease of Opportunity. Journal of fungi (Basel, Switzerland), 6(1), 15. https://doi.org/10.3390/jof6010015

Chitapanarux, I., Wongsrita, S., Sripan, P., Kongsupapsiri, P., Phakoetsuk, P., Chachvarat, S., & Kittidachanan, K. (2021). An underestimated pitfall of oral candidiasis in head and neck cancer patients undergoing radiotherapy: an observation study. BMC oral health, 21(1), 353. https://doi.org/10.1186/s12903-021-01721-x

Thomas-White, K. J., Gao, X., Lin, H., Fok, C. S., Ghanayem, K., Mueller, E. R., Dong, Q., Brubaker, L., & Wolfe, A. J. (2018). Urinary microbes and postoperative urinary tract infection risk in urogynecologic surgical patients. International urogynecology journal, 29(12), 1797–1805. https://doi.org/10.1007/s00192-018-3767-3

Komesu, Y. M., Dinwiddie, D. L., Richter, H. E., Lukacz, E. S., Sung, V. W., Siddiqui, N. Y., Zyczynski, H. M., Ridgeway, B., Rogers, R. G., Arya, L. A., Mazloomdoost, D., Levy, J., Carper, B., Gantz, M. G., & Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network (2020). Defining the relationship between vaginal and urinary microbiomes. American journal of obstetrics and gynecology, 222(2), 154.e1–154.e10. https://doi.org/10.1016/j.ajog.2019.08.011

Tille PM, Forbes BA. Bailey & Scott’s diagnostic microbiology .13th ed. Louis: Elsevier; 2014.

Deorukhkar, S. C., Saini, S., & Mathew, S. (2014). Virulence Factors Contributing to Pathogenicity of Candida tropicalis and Its Antifungal Susceptibility Profile. International journal of microbiology, 2014, 456878. https://doi.org/10.1155/2014/456878

Mulet Bayona, J. V., Salvador García, C., Tormo Palop, N., Valentín Martín, A., González Padrón, C., Colomina Rodríguez, J., Pemán, J., & Gimeno Cardona, C. (2022). Novel Chromogenic Medium CHROMagarTM Candida Plus for Detection of Candida auris and Other Candida Species from Surveillance and Environmental Samples: A Multicenter Study. Journal of fungi (Basel, Switzerland), 8(3), 281. https://doi.org/10.3390/jof8030281

Kim, D., Shin, W. S., Lee, K. H., Kim, K., Young Park, J., & Koh, C. M. (2002). Rapid differentiation of Candida albicans from other Candida species using its unique germ tube formation at 39 degrees C. Yeast (Chichester, England), 19(11), 957–962. https://doi.org/10.1002/yea.891

Tronchin, G., Pihet, M., Lopes-Bezerra, L. M., & Bouchara, J. P. (2008). Adherence mechanisms in human pathogenic fungi. Medical mycology, 46(8), 749–772. https://doi.org/10.1080/13693780802206435

Tsui, C., Kong, E. F., & Jabra-Rizk, M. A. (2016). Pathogenesis of Candida albicans biofilm. Pathogens and disease, 74(4), ftw018. https://doi.org/10.1093/femspd/ftw018

Sultan, A. M., & Nabiel, Y. (2019). Tube method and Congo red agar versus tissue culture plate method for detection of biofilm production by uropathogens isolated from midstream urine: Which one could be better?. African journal of clinical and experimental microbiology, 20(1), 60-66.‏ https://doi.org/10.4314/ajcem.v20i1.9

Romo, J. A., Rodrigues, M. E. C., Fernandes, L. S., Papp, C., Gácser, A., & Rodrigues, C. F. (2019). Advances in Candida sp. Biofilm Mannans.‏

Pereira, R., Dos Santos Fontenelle, R. O., de Brito, E. H. S., & de Morais, S. M. (2021). Biofilm of Candida albicans: formation, regulation and resistance. Journal of applied microbiology, 131(1), 11–22. https://doi.org/10.1111/jam.14949

Ponde, N. O., Lortal, L., Ramage, G., Naglik, J. R., & Richardson, J. P. (2021). Candida albicans biofilms and polymicrobial interactions. Critical reviews in microbiology, 47(1), 91-111.

Downloads

Published

2024-08-05

How to Cite

Al-sabti, K. H. J., & Ali Hussain Shabaa, R. (2024). Relationship of biofilm strength levels in Candida albicans isolates with the type of clinical specimens: علاقة مستويات قوة الغشاء الحيوي في عزلات المبيضات البيضاء بنوع العينات السريرية. Al-Kufa University Journal for Biology, 16(2), 30-39. https://doi.org/10.36320/ajb/v16.i2.16560

Share